The Only Two Bets BlueYard Will Make: Utopia or Oblivion

Most venture firms open with a market. BlueYard Capital opens with a question, printed on its homepage in place of a pitch: will it be utopia, or oblivion? The firm has built a roughly $500 million business around the belief that those are the only two directions that matter, and that a fund should only write checks that push toward the first or hold back the second. It is an unusually narrow way to run an early-stage fund. It has also, so far, worked.

Founded in 2016 by Ciarán O'Leary and Jason Whitmire - two partners who left Berlin's Earlybird Venture Capital to start something of their own - BlueYard set out to back technical founders working on civilization-scale problems that other investors found too early, too strange, or too risky to touch. The firm calls these "n-of-1" companies: the only one of their kind doing the thing. Nearly a decade later, the portfolio reads like an index of ideas that once sounded like science fiction and now sound like infrastructure.

A thesis you can fit on a napkin

BlueYard's own words are blunt: "We invest in only two kinds of technologies: those that move us toward utopia, and those that hold the line against oblivion." Underneath that binary sits a more practical map. The firm sorts its work into four theses, and every company it backs is meant to sit inside one of them.

What it actually does

Strip away the manifesto and BlueYard is a classic early-stage venture fund: it raises money from limited partners, invests that money as equity in young companies, and earns management fees plus a share of the profits when those companies succeed. What separates it from the field is discipline of scope. The firm writes checks of $500K to $5M, moves at pre-seed through Series A, and typically leads or co-leads the round rather than tagging along. The book is concentrated - a small number of high-conviction bets - instead of the wide, spray-and-pray portfolios common in seed investing.

The partnership is deliberately small and split across two continents, roughly balanced between Berlin and the United States. That transatlantic footprint lets BlueYard chase founders wherever the hard problems are being worked on, rather than defaulting to a single hub. The team runs to roughly 17 to 19 people across investment and operations.

Who it is for

BlueYard has two sets of customers, and they sit on opposite sides of the ledger. On one side are the founders - usually deeply technical people building in frontier science, crypto, and deep tech, at the stage where a company is closer to a research project than a product. These are the founders who get turned away elsewhere because the idea is unproven or the timeline is long. On the other side are the limited partners, the institutions and individuals who put money into BlueYard's funds and, in return, get exposure to a slice of technology risk that is hard to buy anywhere else.

The through-line is patience. A fusion company or a quantum-computing bet does not return capital on a SaaS timetable, and BlueYard's structure is built to wait for it.

The problems it is trying to solve

Each thesis maps to a problem that is genuinely hard and genuinely large. Computation and intelligence is a bet that the world will keep needing faster, cheaper, more specialized compute - the reason a chip company like Groq and a quantum player like IonQ share a folder. Engineering, aerospace, and defense is a bet on physical resilience, whether that is Marvel Fusion trying to make fusion energy real or Castelion building hypersonic defense systems. Biology and chemistry is a bet on longevity and health at the level of cells and molecules. Crypto is a bet that open, decentralized networks make capital and data harder to capture and censor.

None of these are markets you can validate with a quick survey. They are wagers on how the next few decades go, which is precisely why BlueYard frames them the way it does.

How it is different

Plenty of firms now say "deep tech" and "frontier." What sets BlueYard apart is that the label came first and the fashion followed. It was buying decentralized-storage infrastructure through Protocol Labs and Filecoin before that was a category, and it took positions in Solana, Groq, and IonQ while those still read as research bets. The firm's manifesto, cheekily titled "Put Your Hand in the Box" - a nod to the pain-tolerance test in Frank Herbert's Dune - is really a statement about temperament. BlueYard is looking for founders, and backers, willing to sit with a hard, misunderstood problem long enough to solve it.

That temperament shows up in portfolio construction, too. Instead of many small bets on the safe consensus, BlueYard makes fewer, larger-conviction bets on the uncomfortable one, and concentrates ownership where it believes it is right.

The people making the calls

The firm's General Partner and Chief Technology Officer, Chad Fowler, is an unusual fit for a venture masthead. Before BlueYard, Fowler co-founded Ruby Central, helped organize the original RailsConf, and served as CTO of Berlin's 6Wunderkinder, where he led the engineering behind the productivity app Wunderlist before Microsoft acquired the company in 2015. He then spent time at Microsoft in developer-facing roles. It is a builder's résumé, not a banker's - the kind of background that helps a fund do diligence on companies whose core risk is technical rather than commercial.

Co-founders Ciarán O'Leary and Jason Whitmire bring the venture pedigree, having invested together at Earlybird before spinning out to start BlueYard. Around them sits a small partnership spanning the two continents.

Does the math work?

The early evidence is encouraging. Reporting on the firm's returns pointed to a roughly 7x markup on Fund I, the 2016 vintage, which was said to hold an internal rate of return near 53% as of 2024. Those are paper marks, not final distributions, and frontier bets can swing hard in both directions - but they suggest the contrarian picks aged well. The exits back that up: Privy, a crypto-wallet-infrastructure company, was acquired by Stripe after surpassing 100 million user accounts, and IonQ reached the public markets through an IPO.

Where it fits in the market

BlueYard sits in a competitive band of frontier-focused funds - firms like Founders Fund, Lux Capital, and Union Square Ventures in the US, a16z's crypto arm on the token side, and European early-stage players such as Earlybird and Point Nine on home turf. What distinguishes BlueYard within that group is the tightness of its story. It does not spread across every trend; it holds one belief and applies it consistently, which makes it legible to founders working on exactly the kind of problem it is looking for. For a technical founder deciding whom to pitch, that clarity is itself a feature - you know within one sentence whether you are a fit.

The lesson worth taking from BlueYard is smaller than a fund and portable to anyone building: stop pitching a market and start pitching a fork in the road. Show the world where your work matters and the world where nobody builds it. BlueYard turned that binary into a $500 million business, and its homepage still asks the same question it started with.

Beyond the check

Because BlueYard leads or co-leads and holds a concentrated position, it tends to be an active first institutional investor rather than a passive name on a large cap table. For a founder building something the rest of the market has not caught up to yet, that early conviction can be worth as much as the capital: it sets the terms, the story, and the signal that follows into later rounds. The firm's blog on Medium and its "Put Your Hand in the Box" manifesto function partly as a filter, telling the right founders that this is a place where a long, hard, unfashionable problem is a feature and not a liability. It is a small fund by the standards of the megafunds, but the specificity is the point - and, judging by Fund I's marks, the specificity has paid.